Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 3
2002 4
2003 5
2004 2
2005 2
2006 4
2007 1
2008 2
2009 3
2010 7
2011 8
2012 10
2013 7
2014 10
2015 9
2016 10
2017 26
2018 18
2019 22
2020 23
2021 31
2022 33
2023 30
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Telomere and telomerase biology.
Giardini MA, Segatto M, da Silva MS, Nunes VS, Cano MI. Giardini MA, et al. Among authors: da silva ms. Prog Mol Biol Transl Sci. 2014;125:1-40. doi: 10.1016/B978-0-12-397898-1.00001-3. Prog Mol Biol Transl Sci. 2014. PMID: 24993696 Review.
Docking Studies for Multi-Target Drugs.
Scotti L, Mendonca Junior FJ, Ishiki HM, Ribeiro FF, Singla RK, Barbosa Filho JM, Da Silva MS, Scotti MT. Scotti L, et al. Among authors: da silva ms. Curr Drug Targets. 2017;18(5):592-604. doi: 10.2174/1389450116666150825111818. Curr Drug Targets. 2017. PMID: 26302806 Review.
The Trypanosomatids Cell Cycle: A Brief Report.
Passos AO, Assis LHC, Ferri YG, da Silva VL, da Silva MS, Cano MIN. Passos AO, et al. Among authors: da silva ms. Methods Mol Biol. 2022;2579:25-34. doi: 10.1007/978-1-0716-2736-5_2. Methods Mol Biol. 2022. PMID: 36045195 Review.
Paradoxical activation of oncogenic signaling as a cancer treatment strategy.
Dias MH, Friskes A, Wang S, Fernandes Neto JM, van Gemert F, Mourragui S, Papagianni C, Kuiken HJ, Mainardi S, Alvarez-Villanueva D, Lieftink C, Morris B, Dekker A, van Dijk E, Wilms LHS, da Silva MS, Jansen RA, Mulero-Sanchez A, Malzer E, Vidal A, Santos C, Salazar R, Wailemann RAM, Torres TEP, De Conti G, Raaijmakers JA, Snaebjornsson P, Yuan S, Qin W, Kovach JS, Armelin HA, Te Riele H, van Oudernaarden A, Jin H, Beijersbergen RL, Villanueva A, Medema RH, Bernards R. Dias MH, et al. Among authors: da silva ms. Cancer Discov. 2024 Mar 27. doi: 10.1158/2159-8290.CD-23-0216. Online ahead of print. Cancer Discov. 2024. PMID: 38533987
Multi-Target Drugs for Neglected Diseases.
Scotti L, Filho FJ, de Moura RO, Ribeiro FF, Ishiki H, da Silva MS, Filho JM, Scotti MT. Scotti L, et al. Among authors: da silva ms. Curr Pharm Des. 2016 May 30;22(21):3135-63. doi: 10.2174/1381612822666160224142552. Curr Pharm Des. 2016. PMID: 26907943 Review.
Computer-aided Drug Design Applied to Parkinson Targets.
Ishiki HM, Filho JMB, da Silva MS, Scotti MT, Scotti L. Ishiki HM, et al. Among authors: da silva ms. Curr Neuropharmacol. 2018;16(6):865-880. doi: 10.2174/1570159X15666171128145423. Curr Neuropharmacol. 2018. PMID: 29189169 Free PMC article. Review.
Protoberberine alkaloids.
Da-Cunha EV, Fechinei IM, Guedes DN, Barbosa-Filho JM, Da Silva MS. Da-Cunha EV, et al. Among authors: da silva ms. Alkaloids Chem Biol. 2005;62:1-75. doi: 10.1016/s1099-4831(05)62001-9. Alkaloids Chem Biol. 2005. PMID: 16265921 Review. No abstract available.
248 results